Neonc Technologies (NASDAQ:NTHI) CMO Thomas Chen Acquires 2,284 Shares of Stock

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) CMO Thomas Chen acquired 2,284 shares of the firm’s stock in a transaction on Tuesday, November 10th. The stock was purchased at an average price of $4.38 per share, for a total transaction of $10,003.92. Following the acquisition, the chief marketing officer directly owned 29,519 shares in the company, valued at $129,293.22. This represents a 8.39% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website.

Neonc Technologies Stock Performance

NTHI opened at $4.85 on Friday. Neonc Technologies Holdings, Inc. has a twelve month low of $2.50 and a twelve month high of $11.81. The firm’s 50-day moving average price is $3.30 and its 200 day moving average price is $5.29.

Neonc Technologies (NASDAQ:NTHI) last released its quarterly earnings data on Thursday, November 5th. The company reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.25) by ($0.03).

Analysts Set New Price Targets

Several equities research analysts recently commented on NTHI shares. Wall Street Zen raised Neonc Technologies from a “sell” rating to a “hold” rating in a report on Saturday, November 7th. Zacks Research upgraded Neonc Technologies from a “strong sell” rating to a “hold” rating in a report on Thursday, November 5th. Roth Capital assumed coverage on Neonc Technologies in a research note on Thursday, September 24th. They issued a “buy” rating for the company. Weiss Ratings lowered shares of Neonc Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, October 21st. Finally, BTIG Research reaffirmed a “buy” rating and set a $15.00 price target on shares of Neonc Technologies in a research report on Tuesday, September 8th. Four equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Neonc Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $16.00.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in NTHI. Bank of America Corp DE increased its holdings in shares of Neonc Technologies by 5.0% in the 1st quarter. Bank of America Corp DE now owns 235,396 shares of the company’s stock valued at $1,650,000 after acquiring an additional 11,108 shares during the last quarter. Westmount Partners LLC raised its holdings in Neonc Technologies by 355.2% during the second quarter. Westmount Partners LLC now owns 197,178 shares of the company’s stock worth $893,000 after purchasing an additional 153,858 shares in the last quarter. BlackRock Inc. purchased a new stake in shares of Neonc Technologies during the 2nd quarter worth approximately $815,000. Finally, Global Retirement Partners LLC acquired a new position in shares of Neonc Technologies in the 2nd quarter valued at $126,000.

About Neonc Technologies

NeOnc Technologies Holdings, Inc. is a biotechnology company developing treatments for brain tumors and other central nervous system cancers. Its research focuses on approaches intended to deliver therapies to the brain, where the blood-brain barrier can limit the effectiveness of conventional treatments. The company’s pipeline includes NEO100, a formulation of perillyl alcohol designed for intranasal delivery, and NEO212, a compound combining perillyl alcohol with temozolomide. These candidates are being developed for potential use in brain cancer treatment.